A detailed history of Dlk Investment Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dlk Investment Management, LLC holds 49,182 shares of ABT stock, worth $5.67 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares
49,182
Previous 48,306 1.81%
Holding current value
$5.67 Million
Previous $5.02 Billion 11.71%
% of portfolio
2.15%
Previous 2.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $87,661 - $103,481
876 Added 1.81%
49,182 $5.61 Billion
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $82,800 - $92,425
822 Added 1.73%
48,306 $5.02 Billion
Q1 2024

Apr 12, 2024

BUY
$109.52 - $120.96 $196,588 - $217,123
1,795 Added 3.93%
47,484 $5.4 Billion
Q4 2023

Apr 09, 2024

BUY
$90.19 - $110.4 $4.12 Million - $5.04 Million
45,689 New
45,689 $5.03 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dlk Investment Management, LLC Portfolio

Follow Dlk Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dlk Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dlk Investment Management, LLC with notifications on news.